Apidra 00088-2500
Generic: Insulin Glulisine
Product NDC
00088-2500- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 24, 2009
- Listing Expires
- December 31, 2026
- Application
- BLA021629
Need to source Apidra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Glulisine | 100 [iU]/mL |
Drug Class
Insulin Analog [EPC]Insulin Analog [EPC]Insulin [Chemical/Ingredient]
Packaging Options(2)
1 VIAL, GLASS in 1 CARTON (0088-2500-33) / 10 mL in 1 VIAL, GLASS
1 VIAL, GLASS in 1 CARTON (0088-2500-34) / 10 mL in 1 VIAL, GLASS